@article{a9e88d85392140f1a85b199fb582c504,
title = "Application and potential of artificial intelligence in neonatal medicine",
abstract = "Neonatal care is becoming increasingly complex with large amounts of rich, routinely recorded physiological, diagnostic and outcome data. Artificial intelligence (AI) has the potential to harness this vast quantity and range of information and become a powerful tool to support clinical decision making, personalised care, precise prognostics, and enhance patient safety. Current AI approaches in neonatal medicine include tools for disease prediction and risk stratification, neurological diagnostic support and novel image recognition technologies. Key to the integration of AI in neonatal medicine is the understanding of its limitations and a standardised critical appraisal of AI tools. Barriers and challenges to this include the quality of datasets used, performance assessment, and appropriate external validation and clinical impact studies. Improving digital literacy amongst healthcare professionals and cross-disciplinary collaborations are needed to harness the full potential of AI to help take the next significant steps in improving neonatal outcomes for high-risk infants.",
keywords = "Artificial intelligence, Machine learning, Neonatal medicine",
author = "Kwok, {T'ng Chang} and Caroline Henry and Sina Saffaran and Marisse Meeus and Declan Bates and {Van Laere}, David and Geraldine Boylan and Boardman, {James P} and Don Sharkey",
note = "Funding Information: DVL received funding for technology development through a research grant provided by the University Hospital of Antwerp and a private fund. DVL is the co-owner and an executive board member of Innocens BV who are developing an AI based Clinical decision support system for Neonatal Intensive Care. Funding Information: TCK and DS are supported by the National Institute of Health Research (NIHR) Children and Young People MedTech Co-operative (CYP MedTech). DS has received funding for technology development from the Medical Research Council , NIHR and Action Medical Research , and is a non-executive director of SurePulse Medical who are developing monitoring solutions for neonatal care. Funding Information: TCK and DS are supported by the National Institute of Health Research (NIHR) Children and Young People MedTech Co-operative (CYP MedTech). DS has received funding for technology development from the Medical Research Council, NIHR and Action Medical Research, and is a non-executive director of SurePulse Medical who are developing monitoring solutions for neonatal care. Publisher Copyright: {\textcopyright} 2022 The Authors",
year = "2022",
month = oct,
doi = "10.1016/j.siny.2022.101346",
language = "English",
volume = "27",
journal = "Seminars in Fetal and Neonatal Medicine",
issn = "1744-165X",
publisher = "Elsevier Science",
number = "5",
}